Home
Resources
Diseases
COVID-19
Ebola
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hepatitis B birth dose vaccines
Hexavalent vaccines
HPV vaccines
Malaria vaccines
Measles containing vaccines
PCV vaccines
RSV vaccines
Typhoid Conjugate Vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
COVID-19
Type of publications
Guidelines (1)
NITAG documentation (359)
Reports (2)
SAGE documentation (34)
Scientific publications (4)
Systematic reviews (SYSVAC) (1199)
Regions
Africa (62)
Americas (192)
Eastern Mediterranean (12)
Europe (161)
Global (1)
South-East Asia (12)
Western Pacific (39)
Diseases
COVID-19 (1599)
Chikungunya (13)
Cholera (35)
Cytomegalovirus (1)
Dengue (45)
Diphtheria (92)
Ebola (21)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (72)
Hepatitis A (71)
Hepatitis B (175)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (81)
HIV / AIDS (10)
Human papillomavirus (HPV) (545)
Influenza (639)
Japanese encephalitis (35)
Lyme disease, Borreliosis (2)
Malaria (35)
Measles (148)
Meningococcal disease (157)
Moraxella catarrhalis (1)
Mpox (59)
Mumps (53)
Pertussis (122)
Pneumococcal disease (310)
Poliomyelitis (98)
Q fever (1)
Rabies (33)
Rotavirus (122)
RSV (Respiratory syncytial virus) (71)
Rubella (72)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (73)
Tick-borne encephalitis (14)
Tuberculosis (84)
Typhoid (33)
Varicella (79)
Yellow fever (45)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (14)
Moderate (9)
Low (132)
Critically low (732)
Not applicable (312)
1599 results found
2020
∙
ATAGI
ATAGI COVID-19 Working Group terms of reference and membership
2020
∙
William Gruber, ACIP
BNT162b2 Vaccine Candidate Against COVID-19
2020
∙
CAVEI
CAVEI interim recommendation for the initial prioritization of groups to be vaccinated against SARS-CoV-2 in the context of limited supply
2020
∙
CAVEI
CAVEI Interim statement on target groups for vaccination against SARS-COV-2
2020
∙
CAVEI
CAVEI ordinary meeting August 26th 2020
2020
∙
CAVEI
CAVEI ordinary meeting August 5th 2020
2020
∙
CAVEI
CAVEI ordinary meeting July 29th 2020
2020
∙
CAVEI
CAVEI ordinary meeting June 24th 2020
2020
∙
CAVEI
CAVEI provisional recommendation for the initial prioritization of groups to be vaccinated against SARS-CoV-2 in the context of limited supply
2020
∙
CAVEI
CAVEI recommendations to prioritize vaccination against SARS-COV-2 in health personnel during the campaign initiation phase and in the context of vaccine limited supply
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register
